MAPT and Parkinson disease: This pilot study provides imaging evidence that CSF Aβ1–42 and tau levels negatively correlated with VMAT2 SUVRs in brain regions associated with cognitive dysfunction in PD, indicating a relationship between these pathologic proteins and dopamine degeneration in PD.